N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor

M'KADMI, CÉLINE; CABRAL, AGUSTINA; BARRILE, FRANCO; GIRIBALDI, JULIEN; CANTEL, SONIA; DAMIAN, MARJORIE; MARY, SOPHIE; DENOYELLE, SÉVERINE; DUTERTRE, SÉBASTIEN; PÉRALDI-ROUX, SYLVIE; NEASTA, JÉRÉMIE; OIRY, CATHERINE; BANÈRES, JEAN-LOUIS; MARIE, JACKY; PERELLO, MARIO; FEHRENTZ, JEAN-ALAIN

JOURNAL OF MEDICINAL CHEMISTRY

AMER CHEMICAL SOC

Año: 2019 vol. 62 p. 965 - 973

0022-2623

The ghrelin receptor or growth hormone secretagogue receptor (GHSR) is a G-protein-coupled receptor that controls growth hormone and insulin secretion, food intake, and reward-seeking behaviors. Liver-expressed antimicrobial peptide 2 (LEAP2) was recently described as an endogenous antagonist of GHSR. Here, we present a study aimed at delineating the structural determinants required for LEAP2 activity toward GHSR. We demonstrate that the entire sequence of LEAP2 is not necessary for its actions. Indeed, the N-terminal part alone confers receptor binding and activity to LEAP2. We found that both LEAP2 and its N-terminal part behave as inverse agonists of GHSR and as competitive antagonists of ghrelin-induced inositol phosphate production and calcium mobilization. Accordingly, the N-terminal region of LEAP2 is able to inhibit ghrelin-induced food intake in mice. These data demonstrate an unexpected pharmacological activity for LEAP2 that is likely to have an important role in the control of ghrelin response under normal and pathological conditions.